Action on human fibrinogen of anti-sera against fibrinogen dissociated chains
Soria, J.; Soria, C.; Boulard, C.
Pathologie-Biologie 24 Suppl: 11-14
1976
ISSN/ISBN: 0369-8114 PMID: 64957 Document Number: 109561
The preparation of immune anti-sera against A alpha, B beta and gamma chains of human fibrinogen is described. Using these anti-sera, the authors have shown that the antigenic parts of the gamma chain are masked inside the molecule of fibrinogen and are not accessible on the surface of the molecule.
Document emailed within 1 workday
Related Documents
Princen, H.M.; Moshage, H.J.; Emeis, J.J.; de Haard, H.J.; Nieuwenhuizen, W.; Yap, S.H. 1985: Fibrinogen fragments X, Y, D and e increase levels of plasma fibrinogen and liver mRNAs coding for fibrinogen polypeptides in rats Thrombosis and Haemostasis 53(2): 212-215Soria, J.; Soria, C.; Samama, M.; Poirot, E.; Kling, C. 1976: Human platelet fibrinogen: a protein different from plasma fibrinogen Pathologie-Biologie 24 Suppl: 15-17
Forsberg, P.O. 1989: Dephosphorylation of human fibrinogen, previously phosphorylated in vitro by protein kinase C, by whole blood or intestinal alkaline phosphatase. Effects on thrombin-induced gelation of in vitro dephosphorylated human fibrinogen Thrombosis Research 53(1): 1-9
Dube, R.K.; Sahaa, P.K.; Dube, B.; Katiyar, B.C.; Rao, P.V. 1980: Fibrinogen, fibrinogen degradation products and fibrinolytic activity in cerebrospinal fluid in stroke Indian Journal of Medical Research 72: 454-457
Krause, W.H.; Maus, W. 1975: The transformation fibrinogen-fibrin in umbilical cord blood. a contribution to fetal fibrinogen Die Medizinische Welt 26(48): 2172-2174
Snowden, C.; Houlston, R.; Laker, M.F.; Kesteven, P.; Alberti, K.G.; Humphries, S.E. 1992: Plasma fibrinogen levels and fibrinogen genotype in non-insulin dependent diabetics Disease Markers 10(3): 159-167
Oosthuizen, W.; Vorster, H.H.; Jerling, J.C.; Barnard, H.C.; Smuts, C.M.; Silvis, N.; Kruger, A.; Venter, C.S. 1994: Both fish oil and olive oil lowered plasma fibrinogen in women with high baseline fibrinogen levels Thrombosis and Haemostasis 72(4): 557-562
Liu, Y.; Pan, J.; Wang, S.; Li, X.; Huang, Y. 2002: Beta-fibrinogen gene -455A/G polymorphism and plasma fibrinogen level in Chinese stroke patients Chinese Medical Journal 115(2): 214-216
Lehmer, R.R.; Elias, A.N.; Capdeville, M.J.; Brown, D.R.; Branson, H.E. 1985: Fibrinogen Irvine: a qualitatively abnormal fibrinogen associated with the predisposition to recurrent visceral and peripheral venous thrombosis Journal of the National Medical Association 77(7): 561-565
Seydewitz, H.H.; Gram, J.; Bruhn, H.D.; Witt, I. 1991: Fibrinogen Kiel: a congenital dysfibrinogenaemia with (A alpha-16 Arg----His) substitution characterized by HPLC without prior isolation of fibrinogen Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 2(4): 501-506
Simon, B.; Schneider, J. 1970: Comparative studies on the accuracy of the fibrinogen-polymerisation-time-test. a method of fibrinogen estimation for use in clinic and practice Arztliche Forschung 24(8): 234-239
Saoji, A.M.; Gupta, V.L.; Dubey, G.K.; Raichur, B.S. 1983: Demonstration of MISFi (molecules immunologically similar to fibrinogen) and fibrinogen antibody in various pathological studies using counter immunoelectrophoresis Indian Journal of Pathology and Microbiology 26(2): 89-98
Harfenist, E.J.; Packham, M.A.; Kinlough-Rathbone, R.L.; Mustard, J.F. 1981: Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen Journal of Laboratory and Clinical Medicine 97(5): 680-688
Gadgil, S.S.; Kale, N.R. 1979: Preparation of S-sulpho-fibrinogen chains by sulphitolysis of heat-denatured plasma protein Indian Journal of Biochemistry and Biophysics 16(5): 330-332
Adler, G.; Eichman, W.; Szczepanski, M.; Targonska, I.; Jasinska, A. 1998: Postoperative plasma interleukin-6 in patients with renal cancer correlates with C-reactive protein but not with total fibrinogen or with high molecular weight fibrinogen fraction Thrombosis Research 89(5): 243-248
Jirousková, M.; Smyth, S.S.; Kudryk, B.; Coller, B.S. 2001: A hamster antibody to the mouse fibrinogen gamma chain inhibits platelet-fibrinogen interactions and FXIIIa-mediated fibrin cross-linking, and facilitates thrombolysis Thrombosis and Haemostasis 86(4): 1047-1056
Hiura, H. 2004: Fibrinogen (factor I) and dys (functional) -fibrinogen Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 12): 597-599
Vorlová, Z.; Dyr, I.E. 1979: Effect of fibrin-fibrinogenolysis on the determination of the fibrinogen content and fibrin-fibrinogen degradation products (FDP) by means of the fibrin polymerization time (FPT test) Folia Haematologica 106(5-6): 967-970
Pozdniakova, T.M.; Rybalchuk, V.N.; Il'ina, A.V.; Davidovich, I.A.; Rogozhin, S.V. 1986: Effect of peptides--structural analogs of NH2-terminal sites of fibrin alpha- and beta-chains--on specific binding of the NH2-terminal disulfide bond of fibrin with fibrinogen Ukrainskii Biokhimicheskii Zhurnal 58(2): 10-15
Richter, M.; Cyranka, U.; Markwardt, F. 1990: I-125 labeling of human, rat, and bovine fibrinogen Die Pharmazie 45(3): 200-203